1-Liver Function Test - PO3921596584-773 - 230517 - 125136

PO No :PO3921596584-773
Name : Mr.MAHEAH LOHIA Client Name : 1 MG INTEGRATION - GURUGRAM

Age/Gender : 49/Male DOB: Registration Date : 17-May-23 07:59 AM
Patient ID : 1MG392943 Collection Date : 17/May/2023 07:48AM
Barcode ID/Order ID : D3398067 / 7266958 Sample Receive Date : 17/May/2023 09:11AM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 17/May/2023 10:42AM
BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Interval Method
Liver Function Test

Bilirubin-Total 0.37 mg/dL 0.3 – 1.2 Vanadate oxidation
Bilirubin-Direct 0.04 mg/dL 0.0-0.3 Vanadate oxidation
Bilirubin-Indirect 0.33 mg/dL 0.1-1 Calculated
Protein, Total 7.24 g/dL 5.7–8.2 Biuret
Albumin 4.43 g/dL 3.4-4.8 BCG Dye Binding
Globulin 2.8 g/dl 1.8 - 3.6 Calculated
A/G Ratio 1.58 Ratio 0.8 - 2.1 Calculated
Aspartate Transaminase (SGOT) 15 U/L <34 Modified IFCC
Alanine Transaminase (SGPT) 21 U/L 10-49 Modified IFCC
SGOT/SGPT 0.71 Ratio <1 Calculated
Alkaline Phosphatase 94 U/L 46-116 IFCC Standardization
Gamma Glutamyltransferase (GGT) 18 U/L <73 Modified IFCC
Comment:
LFTS are based upon measurements of substances released from damaged hepatic cells into the blood that gives idea of
the Existence, Extent and Type of Liver damage. - Acute Hepatocellular damage: ALT & AST levels are sensitive index of
hepatocellular damage - Obstruction to the biliary tract,Cholestasis and blockage of bile flow:1) Serum Total Bilirubin
concentration 2) Serum Alkaline Phosphatase (ALP) activity 3) Gamma Glutamyl Transpeptidase (GGTP) 4) 5`-
Nucleotidase - Chronic liver disease: Serum Albumin concentration
Bilirubin results from the enzymatic breakdown of heme. Jaundice is a yellowish discoloration of the skin and mucous
membranes caused by hyperbilirubinemia.
Pre-hepatic or hemolytic jaundice - Abnormal red cells, antibodies,drugs and toxins,Hemoglobinopathies, Gilbert’s
syndrome, Crigler-Najjar syndrome
Hepatic or Hepatocellular jaundice-Viral hepatitis,toxic hepatitis, intrahepatic cholestasis
Post-hepatic jaundice -Extrahepatic cholestasis, gallstones, tumors of the bile duct, carcinoma of pancreas
In viral hepatitis and other forms of liver disease associated with acute hepatic necrosis, serum AST and ALT
concentrations are elevated even before the clinical signs and symptoms of disease appear.
ALT is the more liver-specific enzyme and elevations of ALT activity persist longer than AST activity.
Peak values of aminotransferase activity occur between the seventh and twelfth days. Activities then gradually decrease,
reaching normal activities by the third to fifth week. Peak activities bear no relationship to prognosis and may fall with
worsening of the patient's condition.
Aminotransferase activities observed in cirrhosis vary with the status of the cirrhotic process and range from the upper
Page 1 of 2
PO No :PO3921596584-773
Name : Mr.MAHEAH LOHIA Client Name : 1 MG INTEGRATION - GURUGRAM

Age/Gender : 49/Male DOB: Registration Date : 17-May-23 07:59 AM
Patient ID : 1MG392943 Collection Date : 17/May/2023 07:48AM
Barcode ID/Order ID : D3398067 / 7266958 Sample Receive Date : 17/May/2023 09:11AM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 17/May/2023 10:42AM
BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Interval Method
reference limit to four to five times higher, with an AST/ALT ratio greater than 1. The ratio's elevation can reflect the grade
of fibrosis in these patients. Slight or moderate elevations of both AST and ALT activities have been observed after
administration of various medications and chronic hepatic injury such as (1) hemochromatosis, (2) Wilson disease, (3)
autoimmune hepatitis, (4) primary biliary cirrhosis, (5) sclerosing cholangitis, and (6) a1-antitrypsin deficiency.
AST activity also is increased in acute myocardial infarction, progressive muscular dystrophy and dermatomyositis, reaching
concentrations up to eight times the upper reference limit.Slight to moderate AST elevations are noted in hemolytic
disease.
GGT is a sensitive indicator of the presence of hepatobiliary disease, being elevated in most subjects with liver disease
regardless of cause. Increased concentrations of the enzyme are also found in serum of subjects receiving anticonvulsant
drugs, such as phenytoin and phenobarbital.
*** End Of Report ***
Page 2 of 2
TATA1mg Labs
NABL certificate
and Scope
THANK YOU
for choosing us as your healthcare partner
Tata 1mg Labs, India's trusted diagnostics lab chain, is serving over a million customers each year across
50+ cities. We offer a broad range of tests through an extensive catalog and cutting-edge technology. Our
commitment to providing high-quality healthcare is supported by 11 state-of-the-art laboratories, ensuring
easy access to our services across the country.
Q Delhi (National Reference Lab) Q Gurgaon Q Mumbai Q Pune Q Kolkata
Q Lucknow Q Ahmedabad Q Bangalore Q Chennai Q Hyderabad Q Dehradun
Our Promise
Hygienic In accordance with Expert team Doctor-verified
sample international norms & of medical reports with 3-step
collection clinical safetystandards professionals � review process
Get FREE doctor consultation

on every lab test
=...,,.... 1,...................
Watch how
ma ffii I mbs
Consult top doctors we take care of
from the comfort of your home your sample
CLAIM NOW>
Introducing TATA 1mg
Cancer Care Platf Need more help?

One stop for comprehensive cancer assistance
Information on specialty medicines, oncologists in your city, Callon
diagnostic tests, PSPs & more
1800-102-1618
EXPLORE NOW>
Conditions of Laboratory Testing & Reporting:

Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be
clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report may vary
depending on the assay method used. Test results may show Inter-laboratory variations. Test results are not valid for medico-legal purposes. Please mail
your queries related to test results to Customer Care mail ID [email protected]
Disclaimer: Results relate only to the sample received. Test results marked "BOLD" indicate abnormal results i.e. higher or lower than normal. All lab test
results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes. Partial
reproduction of the test results is not permitted. Also, TA TA 1mg Labs is not responsible for any misinterpretation or misuse of the information. The test
reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only.

1-Liver Function Test - PO3921596584-773 - 230517 - 125136

Uploaded by

Copyright:

Available Formats

1-Liver Function Test - PO3921596584-773 - 230517 - 125136

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

1-Liver Function Test - PO3921596584-773 - 230517 - 125136

Uploaded by

Copyright:

Available Formats

PO No :PO3921596584-773

Name : Mr.MAHEAH LOHIA Client Name : 1 MG INTEGRATION - GURUGRAM

Liver Function Test

Name : Mr.MAHEAH LOHIA Client Name : 1 MG INTEGRATION - GURUGRAM

* End Of Report *

Q Delhi (National Reference Lab) Q Gurgaon Q Mumbai Q Pune Q Kolkata

Q Lucknow Q Ahmedabad Q Bangalore Q Chennai Q Hyderabad Q Dehradun

Get FREE doctor consultation

Introducing TATA 1mg

Cancer Care Platf Need more help?

Conditions of Laboratory Testing & Reporting:

You might also like